U Herrlinger Selected Research

Glioblastoma (Glioblastoma Multiforme)

1/2011	Ifosfamide, carboplatin and etoposide in recurrent malignant glioma.
1/2009	Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.
2/2006	PCV chemotherapy for recurrent glioblastoma.
9/2000	Treosulfan chemotherapy for recurrent malignant glioma.
1/2000	HSV-1 Vectors for Gene Therapy of Experimental CNS Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

U Herrlinger Research Topics

Disease

12	Neoplasms (Cancer) 01/2019 - 01/2000
10	Glioma (Gliomas) 01/2019 - 01/2000
8	Lymphoma (Lymphomas) 11/2011 - 04/2000
5	Glioblastoma (Glioblastoma Multiforme) 01/2011 - 01/2000
4	Infections 04/2001 - 04/2000
3	Neoplasm Metastasis (Metastasis) 02/2016 - 07/2004
3	Brain Neoplasms (Brain Tumor) 08/2010 - 01/2000
2	Meningioma (Meningiomas) 04/2014 - 12/2010
2	Astrocytoma (Pilocytic Astrocytoma) 01/2011 - 09/2000
2	Leukoencephalopathies 08/2010 - 05/2005
2	Myasthenia Gravis 06/2000 - 05/2000
1	Infarction (Infarctions) 04/2014
1	Necrosis 04/2014
1	Sepsis (Septicemia) 04/2014
1	Pneumonia (Pneumonitis) 04/2014
1	Seizures (Absence Seizure) 01/2010
1	Epilepsy (Aura) 01/2010
1	Drug Resistant Epilepsy 01/2010
1	Hypersensitivity (Allergy) 01/2010
1	Breast Neoplasms (Breast Cancer) 11/2008
1	Intraocular Lymphoma 10/2008
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2006
1	Brain Diseases (Brain Disorder) 05/2005
1	Respiratory Insufficiency (Respiratory Failure) 03/2005
1	Medulloblastoma 07/2004
1	Disease Progression 07/2004
1	Progressive Multifocal Leukoencephalopathy 10/2003
1	Pathologic Complete Response 08/2002
1	Fistula 03/2002
1	Gliosarcoma 04/2001
1	Virus Diseases (Viral Diseases) 04/2001
1	Hodgkin Disease (Hodgkin's Disease) 06/2000

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 11/2011 - 01/2001
3	Bevacizumab (Avastin)FDA Link 06/2015 - 12/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2015 - 07/2004
2	Temozolomide (Temodar)FDA LinkGeneric 01/2011 - 05/2002
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2008 - 01/2001
2	Thymidine KinaseIBA 04/2001 - 04/2000
2	ProdrugsIBA 09/2000 - 01/2000
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2000 - 01/2000
2	CytokinesIBA 07/2000 - 01/2000
2	Azathioprine (Imuran)FDA LinkGeneric 06/2000 - 05/2000
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2019
1	Biological ProductsIBA 06/2015
1	Etoposide (VP 16)FDA LinkGeneric 01/2011
1	IceIBA 01/2011
1	Ifosfamide FDA LinkGeneric 01/2011
1	Carboplatin (JM8)FDA LinkGeneric 01/2011
1	PlatinumIBA 08/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2010
1	NimustineIBA 01/2009
1	Teniposide (VM 26)FDA Link 01/2009
1	Retinaldehyde (Retinal)IBA 10/2008
1	Rituximab (Mabthera)FDA Link 03/2006
1	Lomustine (CCNU)FDA Link 02/2006
1	Procarbazine (Matulane)FDA Link 02/2006
1	Vincristine (Oncovin)FDA LinkGeneric 02/2006
1	Imatinib Mesylate (Gleevec)FDA Link 03/2005
1	DNA (Deoxyribonucleic Acid)IBA 10/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2002
1	fialuridineIBA 04/2001
1	beta-Galactosidase (Lactaid)IBA 04/2001
1	Arabinofuranosyluracil (Ara U)IBA 04/2001
1	Cytosine DeaminaseIBA 11/2000
1	treosulfanIBA 09/2000
1	LuciferasesIBA 09/2000
1	Complementary DNA (cDNA)IBA 07/2000
1	Viral ProteinsIBA 07/2000
1	Hexadimethrine BromideIBA 07/2000
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2000
1	MimosineIBA 04/2000

Therapy/Procedure

14	Therapeutics 09/2018 - 01/2000
8	Drug Therapy (Chemotherapy) 01/2011 - 01/2000
4	Radiotherapy 08/2010 - 01/2001
1	Combination Drug Therapy (Combination Chemotherapy) 11/2011
1	Denervation 01/2010
1	Electrodes (Electrode) 01/2010
1	Vitrectomy 10/2008
1	Stem Cell Transplantation 03/2006
1	Aftercare (After-Treatment) 08/2002
1	Combined Modality Therapy 01/2001
1	Salvage Therapy 09/2000